RedC Biotech
PrivateLast Round
Grant
Mar 22, 2022
Total Funding Raised
$1.9M
Company Overview
RedC Biotech is a biotechnology company developing an industrial process to produce universal red blood cells from stem cells for medical transfusions.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
RedC Biotech Comparables
Compare RedC Biotech with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Safi Biotherapeutics | 86% | |
| KaloCyte, Inc. | 77% | |
| HemostOD SA | 75% | |
RedC Biotech Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Mar 22, 2022 | ||||
| Seed | May 1, 2020 | ||||
| Pre Seed | Apr 1, 2018 |
RedC Biotech Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Aviram Family Foundation | Grant |
| PipelBiz | Pre Seed, Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 8, 2025
Monthly visitors increased 52% MoM.
- Oct 26, 2024
Monthly visitors grew 372% MoM, reaching 770.
RedC Biotech Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about RedC Biotech's valuation, stock price, and market status.